ABSTRACT Reactivity of a monoclonal antibody with human Langerhans cells was demonstrated by a double-labeling immunofluorescence technique. Ia-bearing cells of the epidermis (Langerhans cells) were reactive with this antibody both in frozen sections and in cell suspensions prepared from human epidermis. This monoclonal antibody was unreactive with non-Ia-bearing epidermal cells and with peripheral blood B cells, T cells, and monocytes but did bind to 70% of intrathymic lymphocytes. These observations further distinguish Langerhans cells from classical monocytes. Furthermore, this monoclonal antibody is a highly specific marker for the in vivo identification and in vitro isolation of Langerhans cells.
Substantial interest has been focused recently on populations of dendritic mononuclear cells found in thymus, lymph node, and spleen because of the ability of these cells to perform important immunologic functions (1) . Of these cells, epidermal Langerhans cells are the most accessible for study. They localize in a suprabasalar position in the epidermis of all mammalian species studied (2) , and cumulative evidence now suggests that they are the primary immunocompetent cells of the epidermis.
The demonstration that Langerhans cells are the epidermal cells that express Ia (immune response-associated) antigens (3) (4) (5) (6) (7) and that stimulate allogeneic T cells in mixed lymphocyte cultures (8) implicated them as possible targets of the cellular reaction directed against histoincompatible skin allografts. This suggestion has recently received strong support from the experimental observation that corneal allografts, epidermal tissues naturally devoid of Langerhans cells, are not rejected by a host differing from the tissue donor only with respect to Ia antigens (7) .
The capacity of Langerhans cells to present exogenous antigens in vitro to syngeneic T cells (8) and their apposition to mononuclear cells at sites of contact allergic dermatitis suggested an important role for them in contact delayed hypersensitivity (reviewed in ref. 9 ). The finding that skin deficient in Langerhans cells is incapable of initiating a normal delayed hypersensitivity reaction after application of an appropriate antigen supports this impression (10) .
Most of the evidence has suggested that these dendritic epidermal cells are related to monocytes. First, the above described functional properties are generally attributed to monocytes. Second, they appear to be derived from bone marrow precursors which migrate to epidermis and localize in a suprabasalar position (11, 12) . Third, they have membrane receptors for the split product ofthe third component ofcomplement and for the Fc fragment of IgG. Finally, they are clearly distinguishable from B cells or T cells in that they lack endogenously produced surface immunoglobulin and the T-cell membrane receptor for sheep erythrocytes (13) . However, Langerhans cells differ from typical monocytes by the presence of a distinctive cytoplasmic "granule" (14) and by being only moderately phagocytic (reviewed in ref. 15) .
In this paper, we present evidence that human Langerhans cells have a membrane-associated antigen which further distinguishes them from classical monocytes. The monoclonal antibody with specificity for this membrane antigen provides a highly specific marker for the isolation and further characterization of this important cell.
MATERIALS AND METHODS
Monoclonal Antibodies. Seven monoclonal antibodies were tested for reactivity with epidermal cells in frozen sections. Production of these antibodies, the OK series, has been reported. Briefly, they include antibodies that were generated in a mouse hybridoma system by immunization with human erythrocyte-rosette purified peripheral lymphocytes (OKT1, OKT3, OKT4) (16) (17) (18) (19) or thymocytes (OKT5, OKT6, and OKT8) (20, 21) and that react selectively with differentiation antigens on these human cells. OKI1 was also generated in a hybridoma system and reacts with a public determinant of human Ia-like antigen (22) . The protein content of the antibody solutions undiluted was in the range 2-5 mg/ml in all cases.
Tissue Specimens. Skin specimens were obtained surgically in accordance with the regulations of the Columbia University Investigational Review Board. They were then snap frozen in liquid N2 and maintained in a liquid N2 freezer until they were sectioned.
Indirect Immunofluorescence of Tissue Sections. Frozen sections (4 ,um) of skin were allowed to air dry for 30 min. They were then overlaid with 100 ,ul of the primary antibody at a dilution of 1:100 and placed in a moist chamber at room temperature for 30 min. After two 10-min rinses in phosphate-buffered saline (GIBCO), excess liquid was removed from the slide and the sections were overlaid with 100 ,ul of the second antibody (fluorescein-conjugated goat anti-mouse IgG, Meloy Laboratories, Springfield, VA, lot 92438) at a dilution of 1:20. The slides were again incubated in a moist chamber at room temperature for 30 min. Sections were then rinsed twice in phosphate-buffered saline and placed in a slide rack before immersion in 1 liter ofbuffered saline in the dark with constant stirring for 90 min. Finally, sections were mounted on coverslips with 10% phosphate-buffered saline in glycerin and examined under a Leitz Ortholux II fluorescence microscope.
Double-Staining Technique. Indirect immunofluorescence was performed with OKI1 at a dilution of 1:100 as the primary antibody and rhodamine-conjugated goat anti-mouse immu- The concept that there is an important relationship between the helper T cell and the Langerhans cell in the skin is further supported by two recent studies ofdelayed type hypersensitivity. In the first set of experiments, the capacity of the host to become contact sensitized correlated with the presence of epidermal Langerhans cells. Indeed, attempts to contact-sensitize at skin sites devoid of Langerhans cells resulted in a state of specific unresponsiveness to subsequent challenge (10) . A separate report indicated that, when injected intravenously into a guinea pig, hapten-conjugated epidermal cells enriched for Langerhans cells induced a state ofimmunity to the hapten (36) . This was in distinction to the state of tolerance induced by intravenous injection of hapten-conjugated peritoneal macrophages. Thus, the Langerhans cell may represent a unique type ofcell, similar to the macrophage in function but primed to react preferentially with cells of the helper T-cell lineage.
Studies of Langerhans cells have been severely hampered by the relative difficulty ofisolating them from skin. They comprise 5% of the cells in normal epidermis and, with current technology, epidermal cell suspensions rarely can be enriched for Langerhans cells beyond 35% (8) . The availability of a monoclonal antibody that reacts with Langerhans cells, but not with other epidermal cells, normal blood T cells, B cells, or monocytes, should greatly simplify the investigation of this important cell population. Fluorescence-activated cell sorting using OKT6 should permit isolation of Langerhans cells from epidermis in nearly pure form, and in situ identification ofthese cells in tissue section can be expected to facilitate their characterization in disease states.
